ID   SPHK1_RAT               Reviewed;         383 AA.
AC   Q91V26; Q642F6;
DT   20-MAY-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   24-JUL-2024, entry version 126.
DE   RecName: Full=Sphingosine kinase 1;
DE            Short=SK 1;
DE            Short=SPK 1;
DE            EC=2.7.1.91 {ECO:0000269|PubMed:16118219};
DE   AltName: Full=Acetyltransferase SPHK1;
DE            EC=2.3.1.-;
GN   Name=Sphk1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=11560121; DOI=10.1006/geno.2001.6607;
RA   Imamura T., Ohgane J., Ito S., Ogawa T., Hattori N., Tanaka S., Shiota K.;
RT   "CpG island of rat sphingosine kinase-1 gene: tissue-dependent DNA
RT   methylation status and multiple alternative first exons.";
RL   Genomics 76:117-125(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   SUBCELLULAR LOCATION, MUTAGENESIS OF GLY-82, FUNCTION, AND CATALYTIC
RP   ACTIVITY.
RX   PubMed=16118219; DOI=10.1074/jbc.m502207200;
RA   Maceyka M., Sankala H., Hait N.C., Le Stunff H., Liu H., Toman R.,
RA   Collier C., Zhang M., Satin L.S., Merrill A.H. Jr., Milstien S.,
RA   Spiegel S.;
RT   "SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in
RT   sphingolipid metabolism.";
RL   J. Biol. Chem. 280:37118-37129(2005).
RN   [4]
RP   FUNCTION, INDUCTION BY AMYLOID-BETA PROTEIN 42, ACTIVITY REGULATION, AND
RP   CATALYTIC ACTIVITY.
RX   PubMed=26334640; DOI=10.1371/journal.pone.0137193;
RA   Cieslik M., Czapski G.A., Strosznajder J.B.;
RT   "The Molecular Mechanism of Amyloid beta42 Peptide Toxicity: The Role of
RT   Sphingosine Kinase-1 and Mitochondrial Sirtuins.";
RL   PLoS ONE 10:E0137193-E0137193(2015).
RN   [5]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=28284343; DOI=10.1016/j.jneuroim.2017.01.015;
RA   Su D., Cheng Y., Li S., Dai D., Zhang W., Lv M.;
RT   "Sphk1 mediates neuroinflammation and neuronal injury via TRAF2/NF-kappaB
RT   pathways in activated microglia in cerebral ischemia reperfusion.";
RL   J. Neuroimmunol. 305:35-41(2017).
CC   -!- FUNCTION: Catalyzes the phosphorylation of sphingosine to form
CC       sphingosine 1-phosphate (SPP), a lipid mediator with both intra- and
CC       extracellular functions. Also acts on D-erythro-sphingosine and to a
CC       lesser extent sphinganine, but not other lipids, such as D,L-threo-
CC       dihydrosphingosine, N,N-dimethylsphingosine, diacylglycerol, ceramide,
CC       or phosphatidylinositol (Probable) (PubMed:16118219). In contrast to
CC       proapoptotic SPHK2, has a negative effect on intracellular ceramide
CC       levels, enhances cell growth and inhibits apoptosis (By similarity).
CC       Involved in the regulation of inflammatory response and
CC       neuroinflammation. Via the product sphingosine 1-phosphate, stimulates
CC       TRAF2 E3 ubiquitin ligase activity, and promotes activation of NF-
CC       kappa-B in response to TNF signaling leading to IL17 secretion
CC       (PubMed:28284343). In response to TNF and in parallel to NF-kappa-B
CC       activation, negatively regulates RANTES induction through p38 MAPK
CC       signaling pathway. Involved in endocytic membrane trafficking induced
CC       by sphingosine, recruited to dilate endosomes, also plays a role on
CC       later stages of endosomal maturation and membrane fusion independently
CC       of its kinase activity. In Purkinje cells, seems to be also involved in
CC       the regulation of autophagosome-lysosome fusion upon VEGFA (By
CC       similarity). {ECO:0000250|UniProtKB:Q9NYA1,
CC       ECO:0000269|PubMed:16118219, ECO:0000269|PubMed:28284343,
CC       ECO:0000305|PubMed:26334640}.
CC   -!- FUNCTION: Has serine acetyltransferase activity on PTGS2/COX2 in an
CC       acetyl-CoA dependent manner. The acetyltransferase activity increases
CC       in presence of the kinase substrate, sphingosine. During
CC       neuroinflammation, through PTGS2 acetylation, promotes neuronal
CC       secretion of specialized preresolving mediators (SPMs), especially 15-
CC       R-lipoxin A4, which results in an increase of phagocytic microglia.
CC       {ECO:0000250|UniProtKB:Q8CI15}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a sphingoid base + ATP = a sphingoid 1-phosphate + ADP + H(+);
CC         Xref=Rhea:RHEA:51496, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:76941, ChEBI:CHEBI:84410, ChEBI:CHEBI:456216;
CC         EC=2.7.1.91; Evidence={ECO:0000269|PubMed:16118219,
CC         ECO:0000305|PubMed:26334640};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:51497;
CC         Evidence={ECO:0000269|PubMed:16118219};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetyl-CoA + L-seryl-[protein] = CoA + O-acetyl-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:59392, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:15352, ChEBI:CHEBI:29999, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288,
CC         ChEBI:CHEBI:141128; Evidence={ECO:0000250|UniProtKB:Q8CI15};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:59393;
CC         Evidence={ECO:0000250|UniProtKB:Q8CI15};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + sphinganine = ADP + H(+) + sphinganine 1-phosphate;
CC         Xref=Rhea:RHEA:15465, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:57817, ChEBI:CHEBI:57939, ChEBI:CHEBI:456216;
CC         EC=2.7.1.91; Evidence={ECO:0000250|UniProtKB:Q9NYA1};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + sphing-4-enine = ADP + H(+) + sphing-4-enine 1-
CC         phosphate; Xref=Rhea:RHEA:35847, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:57756, ChEBI:CHEBI:60119,
CC         ChEBI:CHEBI:456216; EC=2.7.1.91;
CC         Evidence={ECO:0000250|UniProtKB:Q9NYA1};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-hexadecyl-2-amino-sn-glycerol + ATP = 1-O-hexadecyl-2-
CC         desoxy-2-amino-sn-glycero-3-phosphate + ADP + H(+);
CC         Xref=Rhea:RHEA:41163, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:77786, ChEBI:CHEBI:77787, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:Q9NYA1};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q9NYA1};
CC   -!- ACTIVITY REGULATION: Acetyltransferase activity increases in presence
CC       of the kinase substrate, sphingosine (By similarity). In Purkinje
CC       cells, kinase activity on sphingosine increases in presence of VEGFA
CC       (By similarity). In neurons, kinase activity increases during the first
CC       24h in presence of Amyloid-beta protein 42 to decrease after 96h
CC       (PubMed:26334640). {ECO:0000250|UniProtKB:Q8CI15,
CC       ECO:0000250|UniProtKB:Q9NYA1, ECO:0000269|PubMed:26334640}.
CC   -!- SUBUNIT: Interacts with ACY1 (By similarity). Binds to calmodulin.
CC       Interacts with SPHKAP (By similarity). Interacts with CIB1, the
CC       interaction occurs in a calcium-dependent manner. Interacts with TRAF2
CC       (By similarity). Interacts with EEF1A1; the interaction enhances SPHK1
CC       kinase activity (By similarity). {ECO:0000250|UniProtKB:Q8CI15,
CC       ECO:0000250|UniProtKB:Q9NYA1}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16118219}. Nucleus
CC       {ECO:0000250|UniProtKB:Q9NYA1}. Cell membrane
CC       {ECO:0000250|UniProtKB:Q9NYA1}. Endosome membrane
CC       {ECO:0000250|UniProtKB:Q9NYA1}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q9NYA1}. Membrane, clathrin-coated pit
CC       {ECO:0000250|UniProtKB:Q9NYA1}. Synapse {ECO:0000250|UniProtKB:Q8CI15}.
CC       Note=Translocated from the cytoplasm to the plasma membrane in a CIB1-
CC       dependent manner. Binds to membranes containing negatively charged
CC       lipids but not neutral lipids (By similarity). Recruited to endocytic
CC       membranes by sphingosine where promotes membrane fusion (By
CC       similarity). {ECO:0000250|UniProtKB:Q8CI15,
CC       ECO:0000250|UniProtKB:Q9NYA1}.
CC   -!- TISSUE SPECIFICITY: Expressed in microglia (at protein level).
CC       {ECO:0000269|PubMed:28284343}.
CC   -!- INDUCTION: In neurons, expression increases during the first 24h in
CC       presence of Amyloid-beta protein 42 to decrease after 96h.
CC       {ECO:0000269|PubMed:26334640}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB049571; BAB62320.1; -; mRNA.
DR   EMBL; AB049572; BAB62321.1; -; mRNA.
DR   EMBL; AB049573; BAB62322.1; -; mRNA.
DR   EMBL; AB049574; BAB62323.1; -; mRNA.
DR   EMBL; AB049575; BAB62324.1; -; mRNA.
DR   EMBL; BC081738; AAH81738.1; -; mRNA.
DR   RefSeq; NP_001257736.1; NM_001270807.1.
DR   RefSeq; NP_001257737.1; NM_001270808.1.
DR   RefSeq; NP_001257738.1; NM_001270809.1.
DR   RefSeq; NP_001257739.1; NM_001270810.1.
DR   RefSeq; NP_001257740.1; NM_001270811.1.
DR   RefSeq; NP_596877.2; NM_133386.3.
DR   AlphaFoldDB; Q91V26; -.
DR   SMR; Q91V26; -.
DR   IntAct; Q91V26; 1.
DR   STRING; 10116.ENSRNOP00000072525; -.
DR   ChEMBL; CHEMBL1075107; -.
DR   PhosphoSitePlus; Q91V26; -.
DR   PaxDb; 10116-ENSRNOP00000029296; -.
DR   GeneID; 170897; -.
DR   KEGG; rno:170897; -.
DR   AGR; RGD:620048; -.
DR   CTD; 8877; -.
DR   RGD; 620048; Sphk1.
DR   eggNOG; KOG1116; Eukaryota.
DR   InParanoid; Q91V26; -.
DR   OrthoDB; 374620at2759; -.
DR   PhylomeDB; Q91V26; -.
DR   BRENDA; 2.7.1.91; 5301.
DR   Reactome; R-RNO-1660661; Sphingolipid de novo biosynthesis.
DR   Reactome; R-RNO-390471; Association of TriC/CCT with target proteins during biosynthesis.
DR   Reactome; R-RNO-5218921; VEGFR2 mediated cell proliferation.
DR   Reactome; R-RNO-9009391; Extra-nuclear estrogen signaling.
DR   Reactome; R-RNO-9833482; PKR-mediated signaling.
DR   SABIO-RK; Q91V26; -.
DR   PRO; PR:Q91V26; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0005905; C:clathrin-coated pit; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; ISS:UniProtKB.
DR   GO; GO:0030139; C:endocytic vesicle; ISS:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0098793; C:presynapse; ISO:RGD.
DR   GO; GO:0008021; C:synaptic vesicle; IDA:RGD.
DR   GO; GO:0016407; F:acetyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; ISO:RGD.
DR   GO; GO:0005516; F:calmodulin binding; ISO:RGD.
DR   GO; GO:0017050; F:D-erythro-sphingosine kinase activity; IDA:RGD.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0008289; F:lipid binding; ISS:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; ISS:UniProtKB.
DR   GO; GO:0051721; F:protein phosphatase 2A binding; ISO:RGD.
DR   GO; GO:0008481; F:sphinganine kinase activity; ISS:UniProtKB.
DR   GO; GO:0038036; F:sphingosine-1-phosphate receptor activity; ISO:RGD.
DR   GO; GO:0001568; P:blood vessel development; ISO:RGD.
DR   GO; GO:0007420; P:brain development; ISO:RGD.
DR   GO; GO:0019722; P:calcium-mediated signaling; ISO:RGD.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; IEP:RGD.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IEP:RGD.
DR   GO; GO:0009267; P:cellular response to starvation; IEP:RGD.
DR   GO; GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; ISS:UniProtKB.
DR   GO; GO:0019371; P:cyclooxygenase pathway; IDA:RGD.
DR   GO; GO:0071897; P:DNA biosynthetic process; ISO:RGD.
DR   GO; GO:0007565; P:female pregnancy; IEP:RGD.
DR   GO; GO:0006954; P:inflammatory response; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:RGD.
DR   GO; GO:1900060; P:negative regulation of ceramide biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; ISO:RGD.
DR   GO; GO:0030307; P:positive regulation of cell growth; ISO:RGD.
DR   GO; GO:0030335; P:positive regulation of cell migration; IMP:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0048146; P:positive regulation of fibroblast proliferation; ISO:RGD.
DR   GO; GO:0032740; P:positive regulation of interleukin-17 production; IMP:UniProtKB.
DR   GO; GO:0045931; P:positive regulation of mitotic cell cycle; ISO:RGD.
DR   GO; GO:0045840; P:positive regulation of mitotic nuclear division; ISO:RGD.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IMP:RGD.
DR   GO; GO:0001956; P:positive regulation of neurotransmitter secretion; IMP:RGD.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProtKB.
DR   GO; GO:1901224; P:positive regulation of non-canonical NF-kappaB signal transduction; ISS:UniProtKB.
DR   GO; GO:1900745; P:positive regulation of p38MAPK cascade; ISS:UniProtKB.
DR   GO; GO:0010800; P:positive regulation of peptidyl-threonine phosphorylation; ISO:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IMP:RGD.
DR   GO; GO:0031398; P:positive regulation of protein ubiquitination; ISS:UniProtKB.
DR   GO; GO:0045987; P:positive regulation of smooth muscle contraction; ISO:RGD.
DR   GO; GO:0006473; P:protein acetylation; ISS:UniProtKB.
DR   GO; GO:0030100; P:regulation of endocytosis; ISS:UniProtKB.
DR   GO; GO:1905364; P:regulation of endosomal vesicle fusion; ISS:UniProtKB.
DR   GO; GO:0032651; P:regulation of interleukin-1 beta production; ISO:RGD.
DR   GO; GO:1903978; P:regulation of microglial cell activation; ISS:UniProtKB.
DR   GO; GO:0150077; P:regulation of neuroinflammatory response; IMP:UniProtKB.
DR   GO; GO:0050764; P:regulation of phagocytosis; ISS:UniProtKB.
DR   GO; GO:0010803; P:regulation of tumor necrosis factor-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0014075; P:response to amine; IEP:RGD.
DR   GO; GO:0033198; P:response to ATP; IEP:RGD.
DR   GO; GO:0070555; P:response to interleukin-1; IEP:RGD.
DR   GO; GO:0032026; P:response to magnesium ion; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0032570; P:response to progesterone; IEP:RGD.
DR   GO; GO:0034612; P:response to tumor necrosis factor; ISS:UniProtKB.
DR   GO; GO:0090520; P:sphingolipid mediated signaling pathway; ISO:RGD.
DR   GO; GO:0046512; P:sphingosine biosynthetic process; ISO:RGD.
DR   GO; GO:0006670; P:sphingosine metabolic process; ISS:UniProtKB.
DR   Gene3D; 2.60.200.40; -; 1.
DR   InterPro; IPR017438; ATP-NAD_kinase_N.
DR   InterPro; IPR001206; Diacylglycerol_kinase_cat_dom.
DR   InterPro; IPR050187; Lipid_Phosphate_FormReg.
DR   InterPro; IPR016064; NAD/diacylglycerol_kinase_sf.
DR   PANTHER; PTHR12358; SPHINGOSINE KINASE; 1.
DR   PANTHER; PTHR12358:SF47; SPHINGOSINE KINASE 1; 1.
DR   Pfam; PF00781; DAGK_cat; 1.
DR   SMART; SM00046; DAGKc; 1.
DR   SUPFAM; SSF111331; NAD kinase/diacylglycerol kinase-like; 1.
DR   PROSITE; PS50146; DAGK; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Calmodulin-binding; Cell membrane; Coated pit; Cytoplasm;
KW   Endosome; Kinase; Lipid metabolism; Membrane; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Synapse; Transferase.
FT   CHAIN           1..383
FT                   /note="Sphingosine kinase 1"
FT                   /id="PRO_0000333033"
FT   DOMAIN          12..159
FT                   /note="DAGKc"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00783"
FT   REGION          363..383
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           147..155
FT                   /note="Nuclear export signal 1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NYA1"
FT   MOTIF           161..169
FT                   /note="Nuclear export signal 2"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NYA1"
FT   ACT_SITE        81
FT                   /note="Proton donor/acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NYA1"
FT   BINDING         22..24
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00783"
FT   BINDING         54..58
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00783"
FT   BINDING         79..82
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NYA1"
FT   BINDING         86
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00783"
FT   BINDING         111..113
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00783"
FT   BINDING         178
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NYA1"
FT   BINDING         185
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00783"
FT   BINDING         191
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00783"
FT   BINDING         340..342
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00783"
FT   MOD_RES         193
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NYA1"
FT   MOD_RES         225
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NYA1"
FT   MUTAGEN         82
FT                   /note="G->D: Loss of sphingosine kinase activity."
FT                   /evidence="ECO:0000269|PubMed:16118219"
FT   CONFLICT        299
FT                   /note="V -> L (in Ref. 2; AAH81738)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   383 AA;  42418 MW;  CAAD5817BF4B9507 CRC64;
     MQPADCPRGL LPRPCRVLVL LNPRGGKGKA LKLFQSRVRP LLEEAEVSFK LMLTERQNHA
     RELVCAEELG HWDALAVMSG DGLMHEVVNG LMERPDWESA IQKPLCSLPG GSGNALAASL
     NYYAGHEQVT NEDLLINCTL LLCCRQLSPM NLLSLHTASG RQLYSVLSLS WGFVADVDLE
     SEKYRSLGEI RFTVGTFFRL ASLRIYQGQL AYLPVGKAAS KIPASSLAQK GPANTYLVPL
     EEPVPPHWTV VPEQDFVLVL VLLHTHLSTE MFAAPMGRCE AGVMHLFYIR AGVSRAMLVR
     LFLAMQKGKH MDLDCPYLVH VPVVAFRLEP RNQRGVFSVD GELMVCEAVQ GQVHPNYLWM
     VSGSSDSPSG RDSQRRPPPE EPI
//
